Previsão

Não temos dados de analistas para esta empresa.

Notícias Ir para o feed de notícias

Promino Nutritional Sciences reports 5,100% quarterly revenue increase

For the quarter ended June 30, 2025, Promino Nutritional Sciences reported revenue of CAD 0.5 million, a 5,100% increase compared with last year's CAD 0.0 million. The figures were presented at the financial conference on September 19, 2025. » Mais em finanzen.net
Promino Nutritional Sciences: Q1 EPS CAD 0.02, annual result CAD -0.09 per share and revenue decline

Promino Nutritional Sciences reported earnings per share (EPS) of CAD 0.02 for the quarter ended 31 December 2024 on quarterly revenue of CAD 0.1 million. For the full fiscal year, loss per share was CAD -0.09 versus -0.15 CAD in the prior year. Annual revenue amounted to CAD 0.26 million, a significant decline of 45.83 percent year over year. » Mais em finanzen.net
Cambridge Nutritional Sciences calls annual general meeting for 25 September

Cambridge Nutritional Sciences plc has called its annual general meeting for Thursday, 25 September 2025 at 15:00 at E-space North in Littleport, Ely and has finalised the directors’ report and financial statements for the year ended 31 March 2025. The report will be sent to shareholders next week and published on the company website; Cavendish Capital Markets Limited is acting as adviser. The company is traded on the London AIM under the ticker CNSL. » Mais em de.investing.com

Dados financeiros da empresa

No último ano, Promino Nutritional Sciences Aktie registou receitas de € 2,75 mi e um ganho líquido de -€ 7,11 mi

(EUR)	2022	YoY
Receitas	2,75 mi	67,66%
Ganho bruto	-743,81 mil	711,02%
Ganho líquido	-7,11 mi	16,37%
EBITDA	-6,88 mi	14,75%

Dados fundamentais

Métrica	Valor
Capitalização bolsista	€ 7,73 mi
Número de ações	128,02 mi
Máximo/mínimo de 52 semanas	€ 0,16 - € 0,021
Dividendos	Não
Beta	3,09
PER (PE Ratio)	-0,95
PEG (PEG Ratio)	0,04
P/VC (PB Ratio)	-1,98
P/V (PS Ratio)	2,66

Perfil da empresa

Element Nutritional Sciences Inc. ist ein Nutrazeutik-Unternehmen, das Ernährungsprodukte entwickelt. Das Unternehmen bietet Rejuvenate, eine firmeneigene Formulierung zur Unterstützung des Wiederaufbaus, der Wiederherstellung und der Verjüngung des natürlichen Verlusts an Muskelmasse aufgrund des Alterns oder anderer medizinischer Bedingungen, sowie JAKTRX-Leistungsergänzungsprodukte an. Das Unternehmen vertreibt seine Produkte auch in Geschäften und online. Das Unternehmen war früher unter dem Namen Element Nutrition Inc. bekannt und änderte im Juni 2021 seinen Namen in Element Nutritional Sciences Inc. um. Der Hauptsitz von Element Nutritional Sciences Inc. befindet sich in Burlington, Kanada.